Abstract
In the present study, the expression and the regulation of ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAMDC) was examined in a series of oncogene transformed cell lines. The expression of both ODC and SAMDC was found to correlate with the nature of the oncogene expressed and with the resulting cellular phenotype expressed. This study demonstrates, for the first time, that the expression of both ODC and SAMDC increases as a function of cellular transformation and, in particular, as a function of malignant progression. Ras transformed cells were shown to express a unique regulatory mechanism whereby a co-ordinate up-regulation of the expression of both ODC and SAMDC occurs (via post-transcriptional stabilization of their mRNA transcripts) in the presence of protein synthesis inhibition. Altered expression (and regulation) of both ODC and SAMDC is suggested to constitute an important part of an altered growth regulatory program inherent to oncogene transformed cells, in particular, to transformed cells capable of malignant progression.
Similar content being viewed by others
References
Tabor H, Tabor CW: Polyamines. In: C.H. Richardson, P.D. Boyer, A. Meister (eds). Ann Rev Biochem, Annual Reviews Inc., Palo alto, CA, 53: 749–790, 1984
Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759–774, 1988
Heby O, Persson L: Molecular genetics of polyamine biosynthesis in eukaryotic cells. Trends Biochem Sci 15: 153–158, 1990
Janne J, Alhonen L, Leinonen P: Polyamines: From molecular biology to clinical application. Ann Med 23: 241–259, 1991
Marton LJ, Pegg AE: Polyamines as targets for chemotherapeutic intervention. In: A.K. Cho, T.F. Blaschke, H.H. Loh, J.L. Way (eds). Ann Rev Pharmacol Toxicol, Annual Reviews Inc., Palo Alto, CA, 35: 55–91, 1995
McCann PP, Pegg AE: Ornithine decarboxylase as an enzyme target for therapy. Pharmacol Ther 54: 195–215, 1992
Pegg AE, McCann PP: S-adenoslymethionine decarboxylase as an enzyme target for therapy. Pharmacol Ther 56: 359–377, 1992
Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 243: 249–262, 1986
Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 243: 212–221, 1982
Suorsa A, Hietala O, Pajunen A: Developmental expression of ornithine and S-adenoslymethionine decarboxylases in mouse brain. Biochem Biophys Res Commun 184: 2, 1992
Hurta RAR, Huang A, Wright JA: Basic fibroblast growth factor selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed cells. J Cell Biochem 60: 572–583, 1996
de Bustros A, Baylin SB, Berger CL, Roos BA, Leong SS, Nelkin BD: Phorbol esters increase calcitonin gene transcription and decrease cmyc mRNA levels in cultured human medullary thyroid carcinoma. J Biol Chem 260: 98–104, 1985
McNight GS, Monroe JG: Role of primary response genes in generating cellular response to growth factors. FASEB J 6: 2707–2715, 1992
Patel AR, Li J, Bass BL, Wang J-Y: Expression of the transforming growth factor beta gene during growth inhibition following polyamine depletion. Am J Physiol: 590–598, 1998
Egan SE, McClarty GA, Jarolim L, Wright JA, Spiro L, Hager G, Greenberg AH: Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10 T1/2 and NIH-3T3 cells. Mol Cell Biochem 7: 830–837, 1987
Turley EA, Austen L, Vandeligt K, Clary C: Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras transformed cells. J Cell Biol 112: 1041–1047, 1991
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG: Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265: 966–979, 1994
Paasinen-Sohns A, Holtta E: Cells transformed with ODC, c-Ha-ras, and v-src exhibit MAP kinase/Erk independent constitutive phosphorylation of Sos, Raf, and c-Jun activation domain, and reduced PDGF receptor expression. Oncogene 15: 1953–1966, 1997
Flamigni F, Facchini A, Capanni C, Stefanelli C, Tantini B, Caldarera CM: p44/42 mitogen activated protein kinase is involved in the expression of ornithine decarboxylase in leukaemia L1210 cells. Biochem J 341: 363–369, 1999
Manni A, Wechter R, Gilmour S, Verderame MF, Mauger D, Demers LM: Ornithine decarboxylase over-expression stimulates mitogenactivated protein kinase and anchorage independent growth of human breast epithelial cells. Int J Cancer 70: 175–182, 1997
Chiao PJ, Kannan P, Yim SO, Krizman DB, Wu T-A, Gallick GE, Tainsky MA: Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors. Oncogene 6: 713–720, 1991
Shayovits A, Bachrach U: Ornithine decarboxylase: An indicator for growth of NIH-3T3 fibroblasts and their c-Ha-ras transformants. Biochim Biophys Acta 1267: 107–114, 1995
Sistonen L, Keski-Oja J, Ulmanen I, Hollta E, Wikgren B-J, Alitalo K: Dose effects of transfected c-Ha-ras Vas 12 oncogene in transformed cell clones. Exp Cell Res 168: 518–530, 1987
Shantz LM, Pegg AE: Ornithine decarboxylase induction in transformation by H-ras and RhoA. Cancer Res 58: 2748–2753, 1998
Hollta E, Sistonen L, Alitalo K: The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 263: 4500–4507, 1988
Trimble WS, Johnson PW, Hozumi N, Roder JC: Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature 321: 782–784, 1986
Egan SE, Wright JA, Jarolim L, Yanagihara K, Bassin RH, Greenberg AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987
Egan SE, Jarolim L, Rogelj S, Spearman M, Wright JA, Greenberg AH: Growth factor modulation of metastatic lung colonization. Anticancer Res 10: 1391–1346, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hurta, R.A. Altered ornithine decarboxylase and S-adenosylmethionine decarboxylase expression and regulation in mouse fibroblasts transformed with oncogenes or constitutively active Mitogen-Activated Protein (MAP) kinase kinase. Mol Cell Biochem 215, 81–92 (2000). https://doi.org/10.1023/A:1026539414863
Issue Date:
DOI: https://doi.org/10.1023/A:1026539414863